Polio Cases Drop to 12 in Pakistan and Afghanistan

In 2024, health workers recorded exactly twelve cases of wild poliovirus worldwide. All twelve appeared in two countries: Pakistan and Afghanistan. Thirty years ago, polio paralyzed more than 350,000 children every year across 125 countries. The virus once struck every continent, crippling limbs and sometimes lungs. Today it survives in a shrinking pocket along the Pakistan-Afghanistan border.

The drop to twelve is not luck. It reflects two decades of door-to-door vaccination, cold-chain logistics across mountain passes, and negotiation with communities that sometimes distrust outsiders. Each remaining case is mapped, sequenced, and traced backward through sewage and soil. The virus is cornered, but elimination demands precision. One missed child can restart transmission.

This article explains how vaccination campaigns pushed polio to the brink of extinction, why the last mile is the hardest, and what the final twelve cases teach us about sustaining public health effort when the end feels close but not certain.

Why twelve cases matter when the goal is zero

Polio is one of only three diseases ever targeted for global eradication. Smallpox succeeded in 1980. Rinderpest, a cattle plague, was declared gone in 2011. Polio remains the third candidate. Unlike measles or influenza, which circulate in animal reservoirs or mutate rapidly, poliovirus has no non-human host and a stable genome. Once human transmission stops, the virus disappears forever.

Twelve cases means transmission chains have narrowed to a handful of neighborhoods. Genetic sequencing shows that the viruses circulating in 2024 descend from a single lineage. They are not new introductions; they are remnants. Each infection represents a gap: a child who missed vaccination, a district where workers could not enter, or a family that moved before the second dose.

The number also sets the baseline for 2025. If cases rise, the virus is expanding. If they fall to zero and stay there for three years, the World Health Organization can certify eradication. Twelve is both a milestone and a warning. The virus is weak, but it is not yet extinct.

How oral polio vaccine works in mass campaigns

The vaccine used in Pakistan and Afghanistan is the oral polio vaccine, known as OPV. Two drops on the tongue deliver weakened live virus. The child's gut mounts an immune response, producing antibodies that block future infection. Within days, the vaccinated child sheds weakened virus in stool. In areas with poor sanitation, that shedding can immunize nearby children who never received drops directly.

This indirect protection is why OPV works in outbreak settings. A single campaign can reach children who live beyond roads or clinics. The vaccine does not require syringes, refrigeration during administration, or trained nurses. Community volunteers can carry vials in insulated bags and deliver doses house to house.

The downside is rare. In roughly one case per 2.7 million doses, the weakened virus mutates and regains the ability to paralyze. These vaccine-derived strains can circulate in under-immunized populations. Pakistan and Afghanistan have seen such strains, but aggressive vaccination usually stops them within months. The risk is manageable when coverage stays high.

Obstacles that kept the virus alive in two countries

Geography comes first. The border between Pakistan and Afghanistan is porous. Families cross for trade, weddings, and seasonal work. A child vaccinated in Peshawar may spend the next month in Kandahar, outside the reach of either country's campaign. Coordination between the two national programs improved after 2018, but gaps remain.

Security is the second barrier. Some districts have been inaccessible to vaccination teams for years. In parts of North Waziristan and Helmand, armed groups have banned health workers or demanded that only local residents deliver vaccines. Negotiations sometimes open windows of a few days. Teams vaccinate as many children as possible, then withdraw. The virus hides in these pockets.

Misinformation adds a third layer. Rumors circulate that vaccines cause infertility, contain pork products, or are Western plots. These fears are not uniform. One village may welcome vaccinators while the next refuses. Health workers spend hours in conversation, often returning multiple times before a family agrees. Trust is built slowly, one household at a time.

Nomadic populations present a logistical puzzle. Families move with livestock across provincial borders. A child may be counted as vaccinated in one district but never actually receive drops because the family left before the team arrived. Mobile tracking and cross-border registries have reduced this problem, but it has not disappeared.

What the 2024 cases reveal about transmission patterns

Eight of the twelve cases appeared in southern Afghanistan, in Kandahar and Helmand provinces. These areas have low routine immunization coverage and intermittent access for campaign teams. Genetic analysis shows the viruses are closely related, indicating sustained local transmission rather than multiple reintroductions.

Four cases were recorded in Pakistan, three in Khyber Pakhtunkhwa and one in Balochistan. All four children had either missed vaccination entirely or received only a single dose. Polio vaccine requires multiple doses to build full immunity. A single dose offers partial protection, but the virus can still infect and paralyze.

Environmental surveillance detected poliovirus in sewage samples from districts that reported no clinical cases. This means the virus circulated silently, infecting children who developed no symptoms or only mild illness. For every paralyzed child, epidemiologists estimate that 200 others carry the virus without showing signs. Hidden transmission is the hardest to stop.

Lessons from countries that eliminated polio decades ago

India reported its last case of wild polio in January 2011. The country was once considered the most difficult place to eradicate the disease, with dense slums, massive population movement, and low vaccine coverage in some states. Success came from micro-planning: mapping every neighborhood, tracking every newborn, and deploying thousands of local volunteers who knew which families had refused vaccines.

Nigeria eliminated wild polio in 2020 after years of disruption by insurgency in the northeast. The breakthrough came when health workers negotiated access through traditional and religious leaders, trained local women as vaccinators, and used satellite imagery to identify settlements that had been missed. The lesson was that even prolonged conflict does not make eradication impossible, only harder.

Both countries maintained high routine immunization coverage alongside campaigns. Routine coverage means that children receive polio vaccine as part of standard infant care, during emergency drives. When routine systems are strong, campaigns can focus on high-risk areas rather than the entire population.

What happens after the last case

Eradication is not declared the day the last case recovers. The World Health Organization requires three years of zero cases, with robust surveillance to prove the virus is truly gone. Surveillance includes testing stool samples from children with acute flaccid paralysis, the clinical signature of polio, and collecting sewage from high-risk districts.

Once wild polio is eradicated, countries will phase out the oral vaccine and switch entirely to inactivated polio vaccine, which is given by injection. Inactivated vaccine cannot cause vaccine-derived outbreaks because it contains dead virus. The switch will take years and requires building cold-chain capacity in countries that currently rely on OPV.

Even after eradication, some laboratories and vaccine production facilities will store poliovirus samples. Containment protocols will prevent accidental release. The risk is small but not zero. Smallpox eradication succeeded in part because the virus was confined to two high-security labs. Polio will follow a similar path.

Why the final push is the most expensive per case

In 1988, when the Global Polio Eradication Initiative began, each case cost roughly a few thousand dollars to prevent. Today, preventing one of the final twelve cases costs millions. The math is simple: fixed costs for surveillance, laboratories, campaign logistics, and staff remain high, but the number of cases has plummeted.

Donors sometimes question whether the investment is worth it. The answer lies in the alternative. If eradication fails and polio rebounds, the world could see 200,000 new cases per year within a decade. The cost of controlling endemic polio indefinitely would exceed the cost of finishing eradication many times over.

Economic models show that eradication will save roughly 40 to 50 billion dollars over the next two decades by eliminating the need for vaccination and surveillance. The savings accrue slowly, but they are real. The final twelve cases are a health milestone; they are a financial threshold.

Key facts

• Wild poliovirus now exists in only two countries, down from 125 in 1988.
• Polio vaccine has prevented an estimated 20 million cases of paralysis since 1988.
• One paralyzed child indicates roughly 200 silent infections in the same community.
• Inactivated polio vaccine has been used in most high-income countries since the 1990s.

Can polio return to countries that eliminated it years ago?

Yes, as long as the virus circulates anywhere, it can be reintroduced through travel. Several countries have detected imported cases or vaccine-derived strains after years of zero transmission. Strong routine immunization and surveillance reduce the risk of sustained outbreaks.

Why does eradication take so long when cases are so low?

The virus hides in populations with low vaccine coverage and limited access. Each remaining case requires intensive investigation, environmental sampling, and repeated campaigns in hard-to-reach areas. Eradication is not complete until transmission stops everywhere, in most places.

Related reading: What we do · About us